Location History:
- La Ciotat, FR (2010 - 2018)
- Marseilles, FR (2015 - 2018)
- Marseille, FR (2019)
Company Filing History:
7 out of 18 
5 out of 10 
3 out of 6 
Years Active: 2010-2019
Title: The Innovative Contributions of Francois Romagne
Introduction
Francois Romagne is a notable inventor based in La Ciotat, France. He has made significant contributions to the field of immunology and cancer treatment, holding a total of 12 patents. His work focuses on developing innovative therapies that target immune disorders and cancers.
Latest Patents
Romagne's latest patents include groundbreaking treatments such as anti-KIR combination therapies. These compositions comprise anti-KIR antibodies along with one or more secondary anti-cancer or anti-viral agents. They are designed for use in treating various cancers, including lung cancer, and viral infections like HIV and HCV. Another significant patent involves monoclonal antibodies against NKG2A, which are aimed at treating immune disorders, particularly autoimmune and inflammatory conditions. The methods outlined in this patent involve using antibodies that prevent the stimulation of NKG2A receptors on NK cells, leading to the destruction of dendritic cells that contribute to the pathology of these disorders.
Career Highlights
Throughout his career, Romagne has worked with prominent companies in the biotechnology sector, including Innate Pharma. His innovative approaches and research have positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Romagne has collaborated with esteemed colleagues such as Alessandro Moretta and Pascale Andre. These partnerships have further enhanced his research and contributions to the field.
Conclusion
Francois Romagne's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to advancing treatments for complex health issues. His contributions continue to impact the landscape of immunology and cancer therapy.